Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1985 Aug;20(2):119–128. doi: 10.1111/j.1365-2125.1985.tb05041.x

Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly.

C G Swift, M R Swift, S I Ankier, A Pidgen, J Robinson
PMCID: PMC1400680  PMID: 2864049

Abstract

The pharmacokinetics of the benzodiazepine hypnotic, loprazolam (1.0 mg orally), and the pharmacodynamic response to single oral doses (0.5 mg and 1.0 mg) have been compared in young and elderly healthy volunteers. No difference between the groups in peak plasma concentration (Cmax) or in the time to peak (tmax) was found, but the elimination half-life t1/2,z and area under the plasma concentration-time curve (AUC) were significantly greater in the elderly group. The immediate effects of loprazolam on all three performance tests used (postural sway, critical flicker fusion threshold (CFFT) and choice reaction time (CRT] and on subjective sedation tended to be more pronounced in the elderly subjects, though intersubject variability in response was high in both groups. The corresponding plasma concentrations did not differ significantly between the two groups. The higher (1.0 mg) dosage was associated with significant residual (11 h) impairment of standing steadiness in the elderly subjects. No other hangover effects were observed. The results are compatible with previous evidence of increased 'sensitivity' to benzodiazepines in the elderly and suggest that a lower (0.5 mg) starting dose of loprazolam would be appropriate for older recipients. Further investigation would be necessary to establish whether clinically relevant accumulation of loprazolam occurs in the elderly following repeated dosage.

Full text

PDF
119

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam K., Oswald I., Shapiro C. Effects of loprazolam and of triazolam on sleep and overnight urinary cortisol. Psychopharmacology (Berl) 1984;82(4):389–394. doi: 10.1007/BF00427692. [DOI] [PubMed] [Google Scholar]
  2. Boyd D. H., Ankier S. I. A clinical trial of a new hypnotic--loprazolam. Br J Clin Pract. 1983 Apr;37(4):143–148. [PubMed] [Google Scholar]
  3. Castleden C. M., George C. F., Marcer D., Hallett C. Increased sensitivity to nitrazepam in old age. Br Med J. 1977 Jan 1;1(6052):10–12. doi: 10.1136/bmj.1.6052.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clarke C. H., Nicholson A. N. Immediate and residual effects in man of the metabolites of diazepam. Br J Clin Pharmacol. 1978 Oct;6(4):325–331. doi: 10.1111/j.1365-2125.1978.tb00859.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cook P. J., Flanagan R., James I. M. Diazepam tolerance: effect of age, regular sedation, and alcohol. Br Med J (Clin Res Ed) 1984 Aug 11;289(6441):351–353. doi: 10.1136/bmj.289.6441.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cook P. J., Huggett A., Graham-Pole R., Savage I. T., James I. M. Hypnotic accumulation and hangover in elderly inpatients: a controlled double-blind study of temazepam and nitrazepam. Br Med J (Clin Res Ed) 1983 Jan 8;286(6359):100–102. doi: 10.1136/bmj.286.6359.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Divoll M., Greenblatt D. J., Harmatz J. S., Shader R. I. Effect of age and gender on disposition of temazepam. J Pharm Sci. 1981 Oct;70(10):1104–1107. doi: 10.1002/jps.2600701004. [DOI] [PubMed] [Google Scholar]
  8. Giles H. G., MacLeod S. M., Wright J. R., Sellers E. M. Influence of age and previous use of diazepam dosage required for endoscopy. Can Med Assoc J. 1978 Mar 4;118(5):513–514. [PMC free article] [PubMed] [Google Scholar]
  9. Greenblatt D. J., Allen M. D., Harmatz J. S., Shader R. I. Diazepam disposition determinants. Clin Pharmacol Ther. 1980 Mar;27(3):301–312. doi: 10.1038/clpt.1980.40. [DOI] [PubMed] [Google Scholar]
  10. Greenblatt D. J., Allen M. D., Locniskar A., Harmatz J. S., Shader R. I. Lorazepam kinetics in the elderly. Clin Pharmacol Ther. 1979 Jul;26(1):103–113. doi: 10.1002/cpt1979261103. [DOI] [PubMed] [Google Scholar]
  11. Greenblatt D. J., Allen M. D., Shader R. I. Toxicity of high-dose flurazepam in the elderly. Clin Pharmacol Ther. 1977 Mar;21(3):355–361. doi: 10.1002/cpt1977213355. [DOI] [PubMed] [Google Scholar]
  12. Greenblatt D. J., Allen M. D. Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program. Br J Clin Pharmacol. 1978 May;5(5):407–413. doi: 10.1111/j.1365-2125.1978.tb01646.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greenblatt D. J., Divoll M., Abernethy D. R., Harmatz J. S., Shader R. I. Antipyrine kinetics in the elderly: prediction of age-related changes in benzodiazepine oxidizing capacity. J Pharmacol Exp Ther. 1982 Jan;220(1):120–126. [PubMed] [Google Scholar]
  14. Greenblatt D. J., Divoll M., Puri S. K., Ho I., Zinny M. A., Shader R. I. Clobazam kinetics in the elderly. Br J Clin Pharmacol. 1981 Nov;12(5):631–636. doi: 10.1111/j.1365-2125.1981.tb01281.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hindmarch I. A 1,4-benzodiazepine, temazepam (K 3917), its effect on some psychological parameters of sleep and behaviour. Arzneimittelforschung. 1975 Nov;25(11):1836–1839. [PubMed] [Google Scholar]
  16. Kales A., Scharf M. B., Kales J. D., Soldatos C. R. Rebound insomnia. A potential hazard following withdrawal of certain benzodiazepines. JAMA. 1979 Apr 20;241(16):1692–1695. doi: 10.1001/jama.241.16.1692. [DOI] [PubMed] [Google Scholar]
  17. Klotz U., Avant G. R., Hoyumpa A., Schenker S., Wilkinson G. R. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest. 1975 Feb;55(2):347–359. doi: 10.1172/JCI107938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. MacLeod S. M., Giles H. G., Bengert B., Liu F. F., Sellers E. M. Age- and gender-related differences in diazepam pharmacokinetics. J Clin Pharmacol. 1979 Jan;19(1):15–19. doi: 10.1002/j.1552-4604.1979.tb01612.x. [DOI] [PubMed] [Google Scholar]
  19. Macklon A. F., Barton M., James O., Rawlins M. D. The effect of age on the pharmacokinetics of diazepam. Clin Sci (Lond) 1980 Dec;59(6):479–483. doi: 10.1042/cs0590479. [DOI] [PubMed] [Google Scholar]
  20. McInnes G. T., Bunting E. A., Ings R. M., Robinson J., Ankier S. I. Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic. Br J Clin Pharmacol. 1985 May;19(5):649–656. doi: 10.1111/j.1365-2125.1985.tb02692.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Morgan K., Oswald I. Anxiety caused by a short-life hypnotic. Br Med J (Clin Res Ed) 1982 Mar 27;284(6320):942–942. doi: 10.1136/bmj.284.6320.942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nicholson A. N., Stone B. M. Imidazobenzodiazepines: sleep and performance studies in humans. J Clin Psychopharmacol. 1983 Apr;3(2):72–75. [PubMed] [Google Scholar]
  23. Reidenberg M. M., Levy M., Warner H., Coutinho C. B., Schwartz M. A., Yu G., Cheripko J. Relationship between diazepam dose, plasma level, age, and central nervous system depression. Clin Pharmacol Ther. 1978 Apr;23(4):371–374. doi: 10.1002/cpt1978234371. [DOI] [PubMed] [Google Scholar]
  24. Shader R. I., Greenblatt D. J., Ciraulo D. A., Divoll M., Harmatz J. S., Georgotas A. Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate. Psychopharmacology (Berl) 1981;75(2):193–197. doi: 10.1007/BF00432186. [DOI] [PubMed] [Google Scholar]
  25. Shader R. I., Greenblatt D. J., Harmatz J. S., Franke K., Koch-Weser J. Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J Clin Pharmacol. 1977 Nov-Dec;17(11-12):709–718. doi: 10.1002/j.1552-4604.1977.tb01546.x. [DOI] [PubMed] [Google Scholar]
  26. Shull H. J., Wilkinson G. R., Johnson R., Schenker S. Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med. 1976 Apr;84(4):420–425. doi: 10.7326/0003-4819-84-4-420. [DOI] [PubMed] [Google Scholar]
  27. Skegg D. C., Doll R., Perry J. Use of medicines in general practice. Br Med J. 1977 Jun 18;1(6076):1561–1563. doi: 10.1136/bmj.1.6076.1561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Swift C. G. Postural instability as a measure of sedative drug response. Br J Clin Pharmacol. 1984;18 (Suppl 1):87S–90S. doi: 10.1111/j.1365-2125.1984.tb02586.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Swift C. G., Swift M. R., Hamley J., Stevenson I. H., Crooks J. Side-effect 'tolerance' in elderly long-term recipients of benzodiazepine hypnotics. Age Ageing. 1984 Nov;13(6):335–343. doi: 10.1093/ageing/13.6.335. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES